LEADERSHIP SERIES
Telemedicine Post COVID-19, Hospital at Home and Expansion of Technology
Thursday, April 29 | 11:00 am (CST)
The fee for each session is $25/member and $50/nonmember. If you register for all five sessions of the Leadership series, you will get the fifth session of the respective series free! Contact Cynthia Grinston at [email protected] for assistance in registering for the full series to ensure you receive the discounted offer.
In order to receive CEs, each attendee must register individually. A recording will be provided for all attendees.
AXIS Medical Education designates this continuing nursing education activity for 1.0 contact hour.
Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.
This session is eligible for 1.0 hour of Qualified credit for ACHE Healthcare Executives.
COVID-19 has served as a catalyst across healthcare innovation and delivery. The pandemic has accelerated the digitization and virtualization of healthcare from telemedicine to remote patient monitoring, with long term implications for more continuous, proactive, personalized, anytime, anywhere health and medicine, increasingly moving from the hospital to the home. In this session, Dr. Kraft, who chairs the XPRIZE Pandemic Alliance TaskForce, and is founder of Exponential Medicine, will explore what's emerging and coming next in prevention, diagnostics and therapy and its implications for hospital systems and providers.
Learning Objectives:
• Explain several of the major shifts that have been accelerated in the context of the COVID-19 pandemic and their implications for the future of health and medicine;
• Explore how the pandemic has enabled new forms of diagnostics and therapy that will have impact beyond infectious diseases; and
• Examine how big data, AI and new forms of collaboration have accelerated our understanding of COVID-19, and our ability to respond to and prevent future pandemics.
Daniel Kraft is a Stanford and Harvard trained physician-scientist, inventor, entrepreneur, and innovator. With over 25 years of experience in clinical practice, biomedical research and healthcare innovation, Kraft has chaired the Medicine for Singularity University since its inception in 2008 and is the Founder and Chair of Exponential Medicine, a program that explores convergent, rapidly developing technologies and their potential in biomedicine and healthcare.
He has multiple scientific publications and medical device, immunology and stem cell related patents through faculty positions with Stanford University School of Medicine and as clinical faculty for the pediatric bone marrow transplantation service at University of California San Francisco.
He is the inventor of the MarrowMiner, an FDA approved device for the minimally invasive harvest of bone marrow and founded RegenMed Systems, a company developing technologies to enable adult stem cell-based regenerative therapies. He has conducted research on aerospace medicine that was published with NASA, with whom he was a finalist for astronaut selection.